Preclinical Insights into Evaluating Therapeutic Vaccines for HPV: Tumour Models, Immune Responses, & Translational Tools
Time: 9:45 am
day: Conference Day One
Details:
- Evaluating HPV+ tumour models, highlighting the challenges and opportunities in using inbred vs. outbred mice to study therapeutic vaccines
- Discussing insights from an HPV infection model in NHPs to better understand vaccine performance and immune dynamics
- Outlining the development of an ex vivo assay to simulate vaccination and assess cancer-killing performance of T cells in a translational context
